Viral esophagitis in non-human immunodeficiency virus patients: a case-control study
CONCLUSIONS: The study's findings contribute to a better understanding of the clinical characteristics and risk factors associated with VE in non-HIV patients. The identification of immunosuppression and specific risk factors can aid in early detection, appropriate management, and targeted interventions for VE. Further research is warranted to explore the rising incidence of VE in immunocompetent individuals and to optimize preventive strategies and treatment approaches for this condition.PMID:38716211 | PMC:PMC11074486 | DOI:10.21037/tgh-23-44 (Source: Herpes)
Source: Herpes - May 8, 2024 Category: Infectious Diseases Authors: Ahmad Al-Dwairy Loai Azar Tarek Bakain Akram Ahmad Stephanie Woo Pichayut Nithagon Walid Chalhoub Source Type: research
884 rates of repeat upper endoscopy in non-diabetic adults with glucagon-like-peptide prescription
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Abbinaya Elangovan, Raj Shah Tags: AGA Abstracts Source Type: research
883 outcomes associated with glucagon-like peptide-1 receptor agonist use in patients undergoing outpatient upper endoscopy
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Sarjukumar Panchal, Octavia Pickett-Blakely, Gregory G. Ginsberg, Hansol Kang, Alexandra Leto, Anna M. Goebel, Joshua Atkins, Inuk Zandvakili Tags: AGA Abstracts Source Type: research
Su1100 ASSOCIATION BETWEEN PERIOPERATIVE GLP-1 AGONIST USE AND POST OPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING UPPER ENDOSCOPY
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Duha Zaffar, Muhammad Hamza, Martin B. Borissov, Khris C. Dy, Soo Young Hwang, Pinghsin Hsieh, Jerry Tsai, David U. Lee, Raymond E. Kim Tags: AGA Abstracts Source Type: research
Su1036 GLUCAGON-LIKE-PEPTIDE-1 RECEPTOR AGONISTS (GLP-1RA): IMPACT ON OUTPATIENT UPPER ENDOSCOPY PROCEDURE QUALITY
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Frederick B. Peng, Andres C. Urias Rivera, Samanthika S. Devalaraju, Keith Liu, Robert T. Hashimoto, Elliot Baerman, Scott Larson Tags: AGA Abstracts Source Type: research
Sa1362 HELICOBACTER PYLORI DETECTION AMONG PATIENTS WITH DYSPEPSIA UNDERGOING ESOPHAGOGASTRODUODENOSCOPY ON PROTON PUMP INHIBITORS -UNPACKING THE GAP BETWEEN GUIDELINES AND CLINICAL PRACTICE.
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Vaneet Jearth, Ashutosh I. Yadav, Purnima Patial, Singh K. Anupam, Arun Kumar Sharma, Aravind Sekar, Jimil Shah, Surinder S. Rana, Usha Dutta Tags: AGA Abstracts Source Type: research
Tu1377 PROPHYLACTIC ENDOTRACHEAL INTUBATION PRIOR TO URGENT ESOPHAGOGASTRODUODENOSCOPY IN SEVERE UPPER GASTROINTESTINAL BLEEDING: A SYSTEMATIC REVIEW AND META-ANALYSIS.
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Saqr Alsakarneh, Laith Numan, Hasan Sqour, Fouad Jaber, Mahmoud Y. Madi, Maya Mahmoud, Hassan Ghoz, Rajiv Chhabra, Fazel Dinary, Marina Kim Tags: AGA Abstracts Source Type: research
Tu1135 HIGH INCIDENCE OF ABNORMALITIES SEEN ON SCREENING UPPER ENDOSCOPY IN PATIENTS WITH FANCONI ANEMIA
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Joshua A. Sloan, Nicha Wongjarupong, Vikram Christian, Nabeel Azeem, Kevin O. Turner, Margaret MacMillan, John E. Wagner Tags: AGA Abstracts Source Type: research
Mo2004 COLONOSCOPY PREPARATION MAY MITIGATE FOOD RETENTION IN PATIENTS USING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS WHO ARE UNDERGOING UPPER ENDOSCOPY
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Jason Nasser, Ali Rezaie, Ava Hosseini, Mohamad Rashid, Daniel Brimberry, Sepideh Mehravar, Mark Pimentel, Roma Gianchandani, Ruchi Mathur Tags: AGA Abstracts Source Type: research
Mo2002 INCREASED RISK OF RESIDUAL GASTRIC CONTENT IN PATIENTS ON GLP-1 AGONISTS UNDERGOING ESOPHAGOGASTRODUODENOSCOPY
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Lee Meluban, Ari Alter, Mitchell Spinnell Tags: AGA Abstracts Source Type: research
Tu2033 EVALUATING THE UTILITY OF CHATGPT OVER TRADITONAL SEARCH ENGINE QUERY FOR POST-UPPER ENDOSCOPY PATIENT CONCERNS
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Christopher B. Swisher, Loren Rabinowitz, Joseph D. Feuerstein Tags: AGA Abstracts Source Type: research
Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research
Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology : WJG - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research
Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research
Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology : WJG - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research
